best stock tips: Chiasma, Inc.(CHMA)
Advisors' Opinion:- [By Lisa Levin]
Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration's decision on Friday to approve or reject the company's therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street's biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma's capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.
source from Top Stocks For 2015:http://www.topstocksblog.com/best-stock-tips.html
